Carbohydrate-based anti-bacterial and anti-cancer vaccines

Vaccine development is an enormous leap in the world of scientific and therapeutic fields. Carbohydrates pose as a promising candidate for vaccine development. With proper identification and isolation of the active carbohydrate antigens, their synthetic protocols and the practical strategy behind their increase in antigenicity, carbohydrate based vaccines have shown widespread development and acceptance in the scientific community. This chapter describes the overall principle behind the development and design of glycoconjugate vaccines. It also covers their synthetic steps, systematic strategy of vaccine development and commercialization as well as the various progress achieved in the domain of carbohydrate based anti bacterial, anti tumour and anti cancer vaccines.